Unknown

Dataset Information

0

Sleeping Beauty Transposition of Chimeric Antigen Receptors Targeting Receptor Tyrosine Kinase-Like Orphan Receptor-1 (ROR1) into Diverse Memory T-Cell Populations.


ABSTRACT: T cells modified with chimeric antigen receptors (CARs) targeting CD19 demonstrated clinical activity against some B-cell malignancies. However, this is often accompanied by a loss of normal CD19+ B cells and humoral immunity. Receptor tyrosine kinase-like orphan receptor-1 (ROR1) is expressed on sub-populations of B-cell malignancies and solid tumors, but not by healthy B cells or normal post-partum tissues. Thus, adoptive transfer of T cells specific for ROR1 has potential to eliminate tumor cells and spare healthy tissues. To test this hypothesis, we developed CARs targeting ROR1 in order to generate T cells specific for malignant cells. Two Sleeping Beauty transposons were constructed with 2nd generation ROR1-specific CARs signaling through CD3? and either CD28 (designated ROR1RCD28) or CD137 (designated ROR1RCD137) and were introduced into T cells. We selected for T cells expressing CAR through co-culture with ?-irradiated activating and propagating cells (AaPC), which co-expressed ROR1 and co-stimulatory molecules. Numeric expansion over one month of co-culture on AaPC in presence of soluble interleukin (IL)-2 and IL-21 occurred and resulted in a diverse memory phenotype of CAR+ T cells as measured by non-enzymatic digital array (NanoString) and multi-panel flow cytometry. Such T cells produced interferon-? and had specific cytotoxic activity against ROR1+ tumors. Moreover, such cells could eliminate ROR1+ tumor xenografts, especially T cells expressing ROR1RCD137. Clinical trials will investigate the ability of ROR1-specific CAR+ T cells to specifically eliminate tumor cells while maintaining normal B-cell repertoire.

SUBMITTER: Deniger DC 

PROVIDER: S-EPMC4451012 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature

altmetric image

Publications

Sleeping Beauty Transposition of Chimeric Antigen Receptors Targeting Receptor Tyrosine Kinase-Like Orphan Receptor-1 (ROR1) into Diverse Memory T-Cell Populations.

Deniger Drew C DC   Yu Jianqiang J   Huls M Helen MH   Figliola Matthew J MJ   Mi Tiejuan T   Maiti Sourindra N SN   Widhopf George F GF   Hurton Lenka V LV   Thokala Radhika R   Singh Harjeet H   Olivares Simon S   Champlin Richard E RE   Wierda William G WG   Kipps Thomas J TJ   Cooper Laurence J N LJ  

PloS one 20150601 6


T cells modified with chimeric antigen receptors (CARs) targeting CD19 demonstrated clinical activity against some B-cell malignancies. However, this is often accompanied by a loss of normal CD19+ B cells and humoral immunity. Receptor tyrosine kinase-like orphan receptor-1 (ROR1) is expressed on sub-populations of B-cell malignancies and solid tumors, but not by healthy B cells or normal post-partum tissues. Thus, adoptive transfer of T cells specific for ROR1 has potential to eliminate tumor c  ...[more]

Similar Datasets

| S-EPMC2835211 | biostudies-literature
| S-EPMC7403325 | biostudies-literature
| S-EPMC3586802 | biostudies-literature
| S-EPMC2169419 | biostudies-literature
| S-EPMC5239498 | biostudies-other
| S-EPMC4083583 | biostudies-literature
| S-EPMC3669363 | biostudies-literature
| S-EPMC4764937 | biostudies-literature
| S-EPMC3516389 | biostudies-literature
| S-EPMC9784027 | biostudies-literature